Trial Details
COMPLETEDBasic Information
| Clinical ID | c2602 |
|---|---|
| Identifier | NCT03234907 |
| Trial Title | Vedolizumab Intravenous (IV) Compared to Placebo in Chinese Participants With Crohn's Disease. |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: Vedolizumab IV|DRUG: Placebo |
Participant Information
| Sponsor | Takeda |
|---|---|
| City | Anhui |
| Country/Region | China |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2017-08-03 |
|---|---|
| Primary Completion Date | 2020-08-14 |
| Completion Date | 2020-08-14 |